BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Med’s Industry

AirNexis Secures Global Rights To Phase 2 COPD Asset AN01 In $200 Million Series A Backed By Frazier And OrbiMed

AirNexis acquires exclusive rights to develop AN01 outside of China from Haisco Pharmaceutical Group Company founded by Frazier Life Sciences, which led...

January 12, 2026 | News

One Genomics And CiRA Foundation Forge AI Powered Genome Engineering Alliance To Accelerate De Aging Science

AI-Focused Genomics Company Advancing De-Aging Science Collaborates with Leading iPS Cell Manufacturing and Research Foundation One Genomics, an...

January 12, 2026 | News

Terumo Medical Launches SurTract Safety Syringe In The United States

New, retractable safety hypodermic line offers enhanced safety, reliability and ease of use while minimizing patient discomfort* − Terum...

January 08, 2026 | News

Thermo Fisher Scientific Enrols First Patient In New CorEvitas Obesity Registry

Thermo Fisher Scientific Inc., the world leader in serving science,announced the enrollment of the first patient in the new PPD™ CorEvitas™ Obe...

January 08, 2026 | News

Shanghai Ark Biopharmaceutical Secures NMPA Approval For Azstarys ADHD Treatment In China

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced that China's National Medical Products Administration (NMPA) has approved the New D...

January 07, 2026 | News

Sisram Medical Clears Final Regulatory Step For DAXXIFY Market Entry In China

Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics Portfolio Sisram Medical Ltd (the "Company...

January 06, 2026 | News

How Asia Pacific Is Forcing A Rethink On Surgical Outcomes Measurement

As surgical volumes rise and care pathways grow more complex across Asia Pacific, the limitations of how post operative outcomes are measured are becoming ...

January 05, 2026 | Expert Insight | By editor@biopharmaapac.com

TempraMed Technologies Ltd Expands South Korea Presence With New Commercial Order And Extended Distribution Partnership

TempraMed Technologies Ltd, a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is excited to announc...

January 05, 2026 | News

Amphix Bio Secures $12.5 Million Seed Financing To Advance Neurological Therapies

Amphix Bio announced the initial closing of a $12.5 million seed financing round to advance its lead therapeutic candidates toward human clinical trials an...

January 02, 2026 | News

KORU Medical Submits FDA 510k For FreedomEDGE Use With PHESGO In HER2 Positive Breast Cancer

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on t...

January 01, 2026 | News

KLMBio Accelerates Global Expansion With High Value Human Tissue Based Bone Graft Portfolio

KLMBio, a manufacturer and exporter of human tissue-based medical devices, is accelerating its global business expansion by strengthening its high-value ti...

January 01, 2026 | News

Co Diagnostics Secures First Patent For Point Of Care PCR Platform In Australia

The Australian patent represents the first patent granted for the Company's new point-of-care testing platform Co-Diagnostics, I...

December 31, 2025 | News

UltraGreen Secures Dual Regulatory Approvals In Southeast Asia

UltraGreen has obtained regulatory approvals for both its Verdye in the Philippines and its IC-Flow™ Imaging System V2 in Malaysia ...

December 31, 2025 | News

Sobi Secures Positive CHMP Opinion For Aspaveli In Rare Kidney Diseases

Approximately 8,000 people in Europe are living with C3G or primary IC-MPGN If approved, Aspaveli (pegcetacoplan) would be the first C3G and primary IC-...

December 30, 2025 | News

Stay Connected